Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Video
  4. /
  5. Pompe Disease

Pompe Disease

September 19, 2013[email protected]

Pompe Disease

News

  • Positive FDA Type C Meeting Paves Way for OS Therapies’ OST-HER2 in
  • Immusoft Secures FDA Orphan Drug Designation for ISP-002 in Mucopolysa
  • Actuate Therapeutics Reports Positive Phase II Results for Elraglusib
  • BetaGlue Therapeutics Gets Belgian Approval for YntraDose Trial in Unr
  • Quince Therapeutics Completes Pivotal Phase 3 Trial of eDSP in Ataxia-
More News

Access Programs

  • Jonsson Comprehensive Cancer Center – Progressive Metastatic Cas
  • Massachusetts General Hospital – Healthy Naturally Cycling Women
  • Kite, A Gilead Company – Relapsed/Refractory Primary Mediastinal
  • Kite, A Gilead Company – Relapsed/Refractory High-Grade B-Cell L
  • Kite, A Gilead Company – Relapsed/Refractory Transformed Follicu
More Access Programs
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2025 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo